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Reply 
We thank Wu et al, for their interest in our systematic review and meta-analysis1 and for 
their comments.  
Our primary end point was postoperative infectious complications, and to achieve this aim, 
we ensured that studies met the criterion of reporting infectious complications. Indeed, if 
the primary aim of using probiotics or synbiotics is to reduce infectious complications, then 
any study that failed to report this fundamental outcome was not deemed appropriate for 
inclusion. Based on the Cochrane Handbook for Systematic Reviews of Interventions version 
6.0 (section 3.2.4.1), the measurement of certain outcomes in a study may be an eligibility 
criterion; especially when the review addresses the potential for an intervention (probiotics 
or synbiotics) to prevent a particular outcome (infectious complications).2 In accordance 
with this rationale, studies that used the intervention (probiotics or synbiotics) for purposes 
other than preventing infectious complications and, therefore, did not record infectious 
complications were ineligible. 
Moreover, Berman and Parker3 recommended that meta-analyses should address only one 
or two primary outcomes to focus the analytic process. It is unlikely that all studies relating 
to secondary outcomes would be obtained from the initial electronic search as they were 
not the initial purpose of our analysis.1 Therefore, a completely different protocol and 
search strategy would be required to perform a rigorous meta-analysis on secondary 
outcomes such as length of stay and mortality. This was beyond the scope of our meta-
analysis.1 
We restricted our inclusion criteria to patients undergoing abdominal surgery in an effort to 
maintain sufficient clinical homogeneity in terms of population to provide a meaningful 
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summary. We argue that patients undergoing surgery for congenital heart disease are 
sufficiently different from patients undergoing liver transplantation to the point of 
introducing significant clinical heterogeneity. That, however, does not suggest that 
probiotics are of no benefit in extra-abdominal surgical procedures. 
In the trial sequential analysis (TSA) performed by Wu et al. on our meta-analysis1 the 
cumulative Z-curve crossed both the conventional boundary and the trial sequential 
monitoring boundary for benefit. That is supportive of our conclusion that the use of the 
probiotics led to significant reduction in infectious complications.  
However, it is important to stress that different probiotics and synbiotics differ significantly 
in their effects on the gut microbiome and that it would be inappropriate to extrapolate the 
beneficial effect of one strain or combined preparation to another. Therefore, a TSA 
confirming the efficacy of probiotics or synbiotics taken in isolation could inadvertently be 
misinterpreted. It was for this reason we were cautious not to include a TSA, as it would 
have highlighted benefits of “all probiotics” without the caveat that this benefit is limited to 
only the strains utilised in the studies included in this meta-analysis.1  
There is a fundamental issue in several levels of subgroup analysis in the absence of enough 
studies as all it does is reduce power and reintroduces selection bias. The Cochrane 
Handbook acknowledges the usefulness of subgroup analyses in investigating 
heterogeneity, but stipulates that findings from multiple subgroup analyses may be 
misleading.4 The observational nature of subgroup analyses (as opposed to randomised 
comparisons) increases the risk of false negatives and false positives.5 Due to the potential 
errors that can be introduced by subgroup analyses, we opted to be careful regarding 
splitting participant information into separate analyses.  
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Our meta-analysis strengthens the confidence in the overall benefit of probiotics and 
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